Nodular lymphoid hyperplasia: A marker of low-grade inflammation in irritable bowel syndrome?

doi:10.3748/wjg.v22.i46.10198

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 22, Issue 46

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (17409)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-6) series, Tables (1-2) series.

Item

Count

PDF

692

WORD

296

HTML

12877

Figures (1-6)

346

Tables (1-2)

162

Sum=14373

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1340

Download

1696

Sum=3036

Dec 14, 2016 (publication date) through Jul 20, 2024

Times Cited of This Article

Times Cited (11)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Control Study

World J Gastroenterol. Dec 14, 2016; 22(46): 10198-10209
Published online Dec 14, 2016. doi: 10.3748/wjg.v22.i46.10198

Full Size Figure Download Figure

Figure 1 Study design. NLH: Nodular lymphoid hyperplasia; s-no-NLH: Symptomatic patients without NLH; a-NLH: Asymptomatic subjects; s-NLH: Patients with nodular lymphoid hyperplasia; IBD: Inflammatory bowel disease; CeD: Celiac disease.

Citation: Piscaglia AC, Laterza L, Cesario V, Gerardi V, Landi R, Lopetuso LR, Calò G, Fabbretti G, Brisigotti M, Stefanelli ML, Gasbarrini A. Nodular lymphoid hyperplasia: A marker of low-grade inflammation in irritable bowel syndrome? World J Gastroenterol 2016; 22(46): 10198-10209
URL: https://www.wjgnet.com/1007-9327/full/v22/i46/10198.htm
DOI: https://dx.doi.org/10.3748/wjg.v22.i46.10198